Lamivudine Stavudine & Nevirapine Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Lamivudine 150 mg + Stavudine 30 or 40 mg + Nevirapine 200 mg
Reference Brands: Triomune®(Global)
Category:
Anti Viral
Lamivudine, Stavudine & Nevirapine Tablets, often used in first-line HIV treatment, are available in 150/30/200 mg strength. Trusted brands like Triomune® offer affordable and effective ART. Via PharmaB2B, bulk procurement from WHO-GMP suppliers supports government tenders and HIV care programs in developing regions.
Lamivudine Stavudine & Nevirapine is available in Tablet
and strengths such as Lamivudine 150 mg + Stavudine 30 or 40 mg + Nevirapine 200 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Lamivudine Stavudine & Nevirapine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Lamivudine Stavudine & Nevirapine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Lamivudine, Stavudine & Nevirapine Tablets are a fixed-dose antiretroviral combination widely used in the management of HIV-1 infection, particularly in first-line ART regimens in developing countries. Available in strengths like 150/30/200 mg, this combination ensures improved patient compliance and cost-effective therapy. Marketed under trusted names like Triomune®, the formulation is procured by governments, NGOs, and hospitals across Africa, Asia, and Latin America. Through PharmaB2B platforms, buyers can access high-quality, WHO-GMP-compliant products in bulk for tenders, institutional supply, and public health programs. It remains a vital component in scaling up global HIV treatment access.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing